Co-Diagnostics (CODX) Misses Q3 EPS by 10c

Co-Diagnostics (NASDAQ: CODX) reported Q3 EPS of ($0.04), $0.10 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $5.1 million versus the consensus estimate of $15.33 million.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States
• Orion Digital receives Nasdaq minimum bid price deficiency notice